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Optimization of bacterial growth conditions for using fluorescent biore-
porters in cell culture infection assays 
Abstract: 
While fluorescent bioreporters are no longer a new thing, they are under constant improve-
ment for application in different fields, and one of them is in medical research. They can be 
of a great importance for monitoring bacterial infection diseases and give us information 
about pathogen-drug interaction within the host. In this study, two bioreporters containing 
the gfp gene (IPTG inducible and constitutively expressing reporter gene) were used in uro-
pathogenic E. coli. We tested different bacterial growth conditions and found the optimal 
one that is not affecting GFP fluorescence and also allow process of bacterial internalization 
in bladder cells.   
Keywords: 
Fluorescence, bioreporter, urinary tract infection, E. coli, cell culture infection 
CERCS: 
B230 Microbiology, bacteriology, virology, mycology; T490 Biotechnology 
Bakterite kasvu tingimuste optimeerimine fluorestseeruvate 
bioreporterite kasutamiseks rakukultuuri nakatumise katsetes 
Lühikokkuvõte: 
Kuigi fluorestseeruvaid bioreportereid on kasutatud juba mõnda aega, siis jätkuvalt on vaja 
neid erinevates valdkondades, näiteks meditsiiniuuringutes, rakendamiseks pidevalt 
täiustatud. Bioreporteritel võib olla suur tähtsus bakteriaalsete nakkushaiguste jälgimisel ja 
nad saavad meile teavet patogeeni ja ravimi koostoime kohta peremeesorganismis. 
Käesolevas töös kasutati uropatogeenses E. coli tüves kahte kahte biorporterit, mis sisaldasid 
gfp geeni (IPTG indutseeritav ja konstitutiivselt ekspresseeriv reportergeen). Katsetasime 
erinevaid bakterite kasvutingimusi ja leidsime optimaalse tingimuse, mis ei mõjuta GFP 
fluorestsentsi ning võimaldavad ka bakterite sisenemist põie-epiteeli rakkudes. 
Võtmesõnad: 
Fluorestsents, bioreporter, kuseteede nakkus, E. coli, rakukultuuri nakkus 
CERCS: 
B230 Mikrobioloogia, bakterioloogia, viroloogia, mükoloogia; T490 Biotehnoloogia 
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TERMS, ABBREVIATIONS AND NOTATIONS 
2x YT – 2x yeast tryptone 
AMP – ampicillin 
CFU – colony forming units 
CFU/ml- colony formed units per millilitre 
Em – emission 
Ex – excitation 
FACS – fluorescence-activated single cell sorting 
FBS – fetal bovine serum 
GFP - green fluorescent protein 
IPTG - isopropyl β-D-1-thiogalactopyranoside  
KAN – kanamycin 
LB - lysogeny broth 
LPS – lipopolysaccharide 
MHB – mueller-hinton broth 
MM 4-64 – membrane marker 4-64 
OMPs - outer membrane proteins 
SOB – super optimal broth 
SOY – trypticase soy broth 
UTIs – urinary tract infections 
UT- urinary tract 






UTIs are one of the most infectious diseases (bacterial) worldwide, and they incur one of the 
highest prescriptions for antibiotics. The high occurrence and recurrence of these infections 
lead to extreme repercussions ranging from high medical costs, antibiotic resistance, to 
death. The inappropriate ways of treating UTIs, which mostly focuses on symptom removal 
(due to the consideration that they are extracellular infections), but not eradication of intra-
cellular bacterial reservoirs, is one of the reasons for recurrences and increasing antibiotic 
resistance. The utmost solution of this worldwide problem would be in a discovery and rea-
sonable use of a drug, that can be as effective against extracellular as against intracellular 
bacteria. 
The aim of this study was to test and optimize fluorescence of bioreporters within uropath-
ogenic Escherichia coli (UPEC), to find the most suitable one for usage in subsequent in 
vitro- cell culture infection models. By establishing the infection model using human bladder 
cell line and fluorescent UPEC, we were able to get more information about bacterial local-
ization and pathogenesis process. Aside from this, the model is relevant for testing efficiency 
of both commonly prescribed antibiotics in treatment of UTIs, and new drugs that are still 
in clinical trials. 
In this study, we used UPEC, transformed with plasmids carrying fluorescent proteins. Our 
aim was to define the pre-growth condition which provides the highest and the most stable 
expression of fluorescent protein, but that at the same time do not affect bacterial internali-
zation within bladder cells. For that purpose, we have used flowcytometry (FACS). After-
wards, we infected the bladder cells with the tested bacteria, and checked the internalization 
rate, followed with cytotoxicity assays and confocal microscopy. Through this study, we 
were able to successfully optimize bacterial bioreporters for better cell infection internaliza-
tion, thus, improving the study of UTIs. 
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1 LITERATURE REVIEW 
1.1 Urinary Tract Infections  
Urinary tract infection (UTI) is defined as the presence of microbial pathogens in the urinary 
tract, usually at very high concentration reaching ≥ 105 colony forming units per ml 
(CFU/ml). However, some pathogens can cause symptoms at much lower concentrations 
starting from 103 CFU/ml.  UTIs can affect both men and women, but it is mostly considered 
a women’s disease, which is predominantly due to the high rate at which it affects women. 
The major reason UTIs are more prevalent in women is due to their shorter urethra compared 
to men, and this makes it easier for bacteria to travel up the urinary tract to the bladder. 
About 150 million people around the world suffer from UTIs each year, with annual increase 
in occurrence of about 12.6% in women, and 3% in men. It has been found that at least, 
about 50% of women and 12% of men will suffer from a UTI in their lifetime (Jhang & Kuo, 
2017; McLellan & Hunstad, 2016). 
By the site of infection, UTIs can be classified as upper (kidneys) or lower (bladder, urethra) 
UTIs (see Figure.1). The second classification is based on the infection complexity which 
consists of uncomplicated and complicated UTIs. Uncomplicated UTIs occur in individuals 
with a non-complex urinary system, i.e., not involving instrumentation. On the other hand, 
complicated UTIs are diagnosed in individuals with complex urinary systems involving both 
structural and functional problems e.g., urethral catheter (Schmiemann & Hummers-Pradier, 
2007). Thirdly, UTIs can also be classified based on how they were acquired on community 
acquired or hospital acquired (mostly involving catheterization). And finally, UTIs can be 
asymptomatic and symptomatic, depending on presence or absence of symptoms. The symp-
toms of UTIs range from mild to severe, including painful, recurrent, and pressing need to 
urinate, pain of the lower back, pelvic region pain, nausea, vomiting, fever, pyuria (cloudy 
or smelly) and haematuria (blood in urine) (Anderson et al., 2004; Terlizzi et al., 2017). The 
transition from asymptomatic to symptomatic infection depends on both human and bacterial 
features, e.g. host age, previous UT infections, gender, or from bacterial side production of 
bacteriocins, toxins, and siderophores. The most frustrating part of these infections is the 
high rate of recurrence. Having >3 UTIs within 12 months as well as >2 within 6 months 
defines a recurrent infection (Terlizzi et al., 2017). Various research has shown that approx-
imately 26% of women with severe UTIs will have a recurrence in the space of six months, 
and many others will have multiple recurrences (Foxman, 2003; Foxman et al., 2000). The 
new episode of UTIs could be a result of a reinfection with the same or different bacterial 
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species, while a relapse is an infection that is usually caused by the same clone that caused 
the initial infection, and it usually happens within 1-2 week after the end of treatment (Geer-
lings, 2016). Recurrent UTIs being a predominant problem on its own can also lead to prob-
lems like renal scarring, antibiotic resistance, and bladder cancer (Anderson et al., 2004; Eto 
et al., 2006). 
 
 
Figure 1. An illustration showing the urinary tract, and sites of infection. The left part of 
the illustration shows upper urinary tract (kidney, ureters) and lower urinary tract (bladder, 
prostrate, urethra). Right side shows moving bacteria with extended pili and flagella, as the 
most important virulence factors in the first phases of establishing of infection.  Adapted 
from Terlizzi et al., 2017. 
UTIs are associated with different types of bacteria. These can include uropathogenic Esch-
erichia coli (UPEC), Staphylococcus saprophyticus, Klebsiella proteus, Pseudomonas aeru-
ginosa, and Enterococcus faecalis.  Enterobacter, E. coli, and S. saprophyticus are usually 
linked with population acquired uncomplicated infections, while the rest are associated with 
irregular uncomplicated cystitis (bladder infection) and pyelonephritis (kidney infection). 
Rarely, one might acquire a UTI involving Staphylococcus aureus. Among the previously 
mentioned UTIs-associated bacterial species, the most common causative agent of UTIs is 
UPEC, which is found in approximately 90% of all infections (Anderson et al., 2004; 





As stated earlier, the primary agent associated with UTIs is UPEC. It belongs to a group of 
extraintestinal pathogenic E. coli that might have originated from the gut (Kot, 2019; 
Schmiemann & Hummers-Pradier, 2007). However, unlike gut E. coli, UPEC contains mo-
bile genetic elements known as pathogenicity islands (PAIs). These islands are genomic re-
gions that aids in the expression of the virulence elements that makes UPEC highly special-
ized in surviving and persisting in the UT (Schmidt & Hensel, 2004). 
There are many variants of UPEC, which can be classified into phylogenetic groups such as 
A, B1, B2, D and E, based on their genomic similarities (Terlizzi et al., 2017). Majority of 
the UPEC isolates belong to B2 group, e.g. (CFT073, UTI89, J96, NU14 and 536). On the 
other hand, UPEC strains from other phylogenetic groups have not been properly isolated 
and researched (Lloyd et al., 2007). However, in the research on UTIs, the most toxic inter-
nalizing UPEC studied in the mouse model is CFT073 (Chockalingam et al., 2019; Sivick et 
al., 2010). It was isolated from the blood of a patient with pyelonephritis (Mobley,’ et al., 
1990). 
1.1.2. UPEC virulence factors 
Virulence elements are essential for bacterial survival and multiplication in UT, and they 
play crucial role in the process of UTI pathogenesis. The most important elements include 
toxins and adhesins, type 1 pilus, curli, outer membrane proteins (OMPs), adhesins, sidero-
phore receptors, lipopolysaccharide (LPS), and flagella (Figure 2) (Anderson et al., 2004; 





Figure 3. UPEC major virulence elements. Virulence factors on the surface of UPEC re-
sponsible for establishing of UT infection. Adapted from Terlizzi et al., 2017. 
Starting with LPS, this molecule’s morphological constituents help in multiple aspects of the 
UPEC life cycle, this stems from the fact that it has amphipathic (one part of the molecule is 
hydrophobic, and the other part is hydrophilic) properties. Colonizing the bladder, forming 
reservoir, evoking bladder’s protective response to bacteria, combined with providing re-
sistance against hydrophobic antibiotics, for which their amphipathic properties are very im-
portant. A decreased expression of LPSs on UPEC’s surface increase susceptibility to hy-
drophobic molecules. Type 1 - and P type pili (associated with the kidney, with the P stand-
ing for pyelonephritis) are also very important molecules synthesized by the fim and pap 
operon, respectively (Anderson et al., 2004; Terlizzi et al., 2017). These pili provide im-
portant adhesins known as PapG and FimH. In the urinary tract, FimH binds mannosylated 
residues from uroplakin molecules on the surface of the urothelium. On the other hand, PapG 
binds to the globoside on the kidney epithelium. PapG is more associated with chronic and 
recurrent UTIs (Anderson et al., 2004; Flores-Mireles et al., 2015; Foxman et al., 2000; 
Terlizzi et al., 2017). Curli grow on the UPEC surface, and they secrete subunits from the 
cell as soluble monomeric proteins, which aids in the formation of biofilms and bacteria 
survival externally (Terlizzi et al., 2017). Curli moderates cellular interactions with other 
cells and surfaces to promote the adhesion of bacteria to other mammalian cells, plant cells, 
and other surfaces, thus it is also important for bacteria internalization, and resistance against 
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urine flow forces threatening to wash it out of the bladder (Allsopp et al., 2012; Cegelski et 
al., 2009; Floyd et al., 2015).  To do this, curli can interact with host glycoprotein and cause 
the clustering of bacterial cells (Zalewska-Piatek & Piatek, 2019). Flagella also play im-
portant roles in biofilm formation. They give invasive properties, their roles are adherence, 
maturation, and dispersal (Cegelski et al., 2009; Floyd et al., 2015; Terlizzi et al., 2017).  
Iron acquisition system is very important for UPEC survival in the urinary tract. It is com-
posed of receptors, known as siderophores, which main role is in capturing of ferric iron.  
Siderophore receptors on the surface of the cell promote iron uptake into the cell with the 
aid of other factors (Terlizzi et al., 2017). 
Finally, UPEC produces different toxins that aid in pathogenesis. One toxin worthy of noting 
is alpha hemolysin which plays a major role in renal scarring and damage and enhances the 
urinary tract colonization by interrupting the normal flow of urine (Allsopp et al., 2012; 
Emody et al., 2003; Schreiber Iv et al., n.d.; Terlizzi et al., 2017). 
Of all these virulence factors, none is solely responsible for the UPEC pathogenesis, but all 
together, the ability to cause UTIs depends on these factors, and these factors have been 
found in most UPEC strains (Allsopp et al., 2012; Emody et al., 2003; Terlizzi et al., 2017). 
1.1.3. UPEC pathogenicity 
Until recently UPEC was considered only as an extracellular pathogen. Its intracellular life-
style and the pathogenic pathway in bladder tissue were first discovered in mice (Barber et 
al., 2016; Carey et al., 2016; Sivick et al., 2010; Vasudevan, 2014). Due to structural simi-
larities with human bladder, mice model has been extensively used in studying UTIs. The 
mice bladder epithelium is, same as human, transient and composed of multiple layers (the 
basal layer, the intermediate layer, and the superficial layer). The epithelium is transient in 
the sense that due to the superficial cells layer being removed every 3-6 months, the lower 
intermediate layer cells are differentiated into the superficial cells, and the basal cells are 
differentiated into the lower intermediate cells (Anderson et al., 2004; Lewis, 2000). The 
superficial layer makes the bladder impermeable. The superficial cells also express integral 
membrane proteins known as uroplakins (UPs). These uroplakins help the integrity of the 
bladder epithelium, provide water impassibility, but they can also contribute to UPEC path-
ogenicity, through UP subunits that allow bacterial attachment to it (Anderson et al., 2004; 
Blango & Mulvey, 2010; Terlizzi et al., 2017). 
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As stated earlier, UPEC expresses several virulence factors that have a role in colonization 
and invasion of the bladder epithelium. UPEC enters the bladder using actin and microtubule 
dependent processes mediated by type 1 pili, then FimH binds mannose containing glyco-
protein receptors containing α3β1 integrin complexes and uroplakin that coat the entire 
internal surface of the bladder. The association of FimH with these uroplakin plaques 
mediates UPECs entry into the superficial bladder cells. Simultaenously, α3β1 integrin 
receptor complexes on the urothelium can also mediate UPEC invasion of the intermediate 
cells. Once internalized, UPEC can be ejected from the cells, or trafficked into the 
endosomes, where they can remain in a quiscent state, bound by the actin filaments. On the 
other hand, in the superficial cells where the actin filaments are rare, UPEC can invade 
adjacent superficial cells and multiply, forming biofilm like inclusions, called intracellular 
bacterial communities (IBCs) (Anderson et al., 2004; Justice et al., 2004; Mulvey et al., 
2001; Terlizzi et al., 2017). 
 
Figure 3. Intracellular lifestyle of UPEC as observed in the murine cystitis model. (A) The 
normal full transitional multilayered urothelium without any affiliation. (B) With the aid of 
pili attachs to UPs on the surface of the bladder epithelium. (C) Through association with 
the UPs, the UPEC invades the cells. (D) While in the cell, they replicate intracellularly to 
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form (E) IBC.  (G) These IBCs can eventually cause a rupture and flux out of the cell. These 
cells might be released into the bladder and cause reinfection of the neighbouring cells, 
additionally, some cells become filamentous and can’t be easily digested by neutrophils.  (F) 
These IBCs can also be evicted from the bladder, by the host cell exfoliation. Adapted from 
David A. Rosen et al., 2007.   
As a host defence mechanism, disruption of the urothelium can occur due to the UPEC in-
duced exfoliation and influx of neutrophils, plus other inflammatory responses, e.g., mucus 
production, secretion of antimicrobial peptides and proteins, proinflammatory chemokines 
etc. (Chromek & Brauner, 2008; Vasudevan, 2014). When the superficial cells are over-
whelmed with bacterial cells, then they initiate apoptosis. The apoptosis leads to the cell’s 
exfoliation their removal from the UT with normal flow of urine. This is very efficient way 
of eradicating most of infected cells, however, bacteria can get easier access and infect un-
derlaying and immature urothelial cells. This can be combated by the superficial cell’s rapid 
regeneration, but it is not enough. In this moment of the bladder’s vulnerability, the bacterial 
cells have an opportunity to go into the basal cells and form quiescent intracellular bacterial 
reservoirs (QIRs) (Chromek & Brauner, 2008; Lewis et al., 2016; Mulvey et al., 2000; 
Terlizzi et al., 2017). Therefore, these defence mechanisms aimed at protecting the host ends 
up enhancing UPEC persistence in the host, alongside IBCs and extracellular biofilms. All 
in all, UPEC have developed mechanisms providing persistence and protection mechanisms. 
The QIRs in the intermediate/basal cells in conjunction with the actin filaments may conceal 
UPEC from many of the host surveillance mechanisms. IBCs and extracellular biofilms pro-
tect UPEC from antimicrobial activities of neutrophils and other host defences (Anderson et 
al., 2003, 2004; David A. Rosen et al., 2007; Eto et al., 2006; Terlizzi et al., 2017). 
1.1.4. Infection models 
There have been various infection models carried out concerning UTIs. These model systems 
are made as an approximation of natural human infections and allow aspects of the infections 
to be controlled (Barber et al., 2016). Pairing known genetic and molecular techniques with 
model systems allow researchers to find key bacterial and host factors involved in UTIs 
pathobiology and identify new therapeutic targets (Barber et al., 2016). There are two com-
mon infection models, the cell culture infection model which we used in this research, and 
the animal infection model (Barber et al., 2016; Carey et al., 2016). 
a. Cell culture infection models 
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Cell culture-based assays have been used extensively to investigate the mechanisms and 
consequences of UPEC interactions with host cells (Blango & Mulvey, 2010; Carey et al., 
2016). These infections are done in addition to primary and cancer cell lines derived from 
the bladder, kidney, or other host cell tissues. These host cells are usually grown as undif-
ferentiated monolayers, but they can be influenced to stratify and partially differentiate when 
grown using appropriate media on membrane scaffold in dishes or appropriate conditions 
(Barber et al., 2016; Blango & Mulvey, 2010). Pharmacological reagents can also be used 
to interfere with host enzymes and signalling cascades, but dosages should be closely mon-
itored. The ease of use, low-cost amenability to high through-put assays, genetic 
manipulation, and biochemical analysis makes cell culture-based systems attractive 
alternative to animal infection models. Flow cell technology even makes it possible to mimic 
urinary tract conditions and examine UPEC-host interactions using bladder cells monolayers 
in the presence of urine flow (Barber et al., 2016). 
b. Animal infection models 
In animal infection models, predominantly murine especially mice, they are used for deci-
phering most of the UPEC pathogenic pathway. In mice, which is the predominant animal 
model for the study of UTIs (Barber et al., 2016; Chockalingam et al., 2019; Justice et al., 
2004; Mulvey et al., 2001), it usually entails the transurethral catheterization of rodents and 
ensuing instillation of bacteria directly into the bladder lumen. Murines share so much in 
common with humans, including conserved immunological factors and similar anatomical 
features within the urinary tract. This model system allows detailed investigation of 
ascending and colonizing UTIs as well as comparing fitness and virulence potentials of wild 
type and mutant UPEC as well as examining host responses to UTI (Barber et al., 2016; 
Carey et al., 2016; Chockalingam et al., 2019). 
Other animal species can also be used to study UTI e.g. humans and other primates, through 
analyzing the urine, zebrafish, swine, avian, nematodes, and teleost (the last five through 
intentional infections) (Barber et al., 2016). 
1.2 Bioreporters 
1.2.1. General description of bioreporters 
Bioreporters are important research tool that give us better understanding of the world of 
microorganisms. They are the result of genetic engineering by which a responsive promoter 
is fused with a suitable reporter gene and then incorporated into bacterial cell (Johan HJ 
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Leveau & Steven E Lindow, 2002). Responsive promoters can respond to changes in envi-
ronmental or metabolic conditions and provide easily measurable signal in return (Kohlmeier 
et al., 2007; Van Der Meer et al., 2004; Yoo et al., 2007). Such properties of a whole-cell 
bioreporters make them applicable in different fields (e.g. detection of pollution in the envi-
ronment, and agriculture, in food control, medical diagnostics and metal detection etc.) 
(Johan HJ Leveau & Steven E Lindow, 2002; van der Meer et al., 2004).    
Bioreporters can be classified either by the ones that increase their output signal when they 
sense specific target compounds (e.g., antibiotics, heavy metals), the ones that increase their 
output signal due to stressful conditions (e.g. pH, oxidative stress), or the ones that increase 
their output signal in reaction to a wide range of conditions (Kohlmeier et al., 2007; Shemer 
et al., 2015; van der Meer et al., 2004).  
 
 
Figure 4. Schematic showing the whole-cell bioreporter. The analyte responsible for in-
ducing the expression of the bioreporter enters the cell. After entering the cell, a regulatory 
protein recognizes and binds to it. This binding leads to the expression of a reporter gene 
and synthesis of a reporter protein, which as a result creates an easily measurable signal. 
Adapted from Shemer et al., 2015. 
There are two types of bioreporters, the lights off, and lights on bioreporters. The lights off 
reporters’ cells are designed to continuously emit light, and the lights on reporters, the prin-
ciple is more complex as the cells are designed to emit light only when exposed to a specific 
substance (Figure 4) (Su et al., 2011; Xu et al., 2013). The lights on bioreporters are designed 
to contain a reporter gene that needs to use an analyte for inducing the expression of its 
signal. The analyte enters the cell, and a regulatory protein recognizes it and binds it to the 
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promoter of the reporter gene. This activates the expression of the mRNA that translates to 
the reporter protein and gives off an easily measurable signal. On the other hand, a lights-
off bioreporter is designed with a reporter gene containing a constitutive promoter that al-
ways activates the expression of the protein responsible for giving of the signal. These sig-
nals can either be bioluminescence (e.g., coded by lux gene), florescence (e.g., coded by gfp 
gene), or colorimetric endpoints (e.g., β-galactosidase coded by lacZ gene) (Kohlmeier et 
al., 2007; Shemer et al., 2015; Su et al., 2011; van der Meer et al., 2004). 
Bioluminescence is the light generation produced due to chemical reaction within a living 
organism and is used in biosensing through a reporter element  (Cevenini et al., 2016; Xu et 
al., 2013). The chemical reaction causing bioluminescence happens when an enzyme reacts 
with a substrate to produce visible light photons (Cevenini et al., 2016; Xu et al., 2013). 
Fluorescence is basically light emission that occurs within nanoseconds after light absorp-
tion. Filtering out source of exciting light without blocking the resulting emission, makes it 
possible to see only fluorescent objects (Lichtman & Conchello, 2005). 
Fluorophores/fluorochromes are molecules containing fluorescent properties (e.g., mem-
brane marker MM 4-64). Absorption of light by a fluorophore leads the molecules to become 
excited to a maximal energy level, and the transition to this state is very swift. This excited 
state only lasts for some nanoseconds, before the molecules move back to the ground state, 
releasing the absorbed energy, this is the emission state of the molecule (Adan et al., 2017; 
Lichtman & Conchello, 2005). 
Fluorescence and fluorochromes typically follows a principle known as Stokes Shift as 
illustrated in the Figure 5. It primarily explains that when light is absorbed and emmited, 
emmision energy contains lower energy than the absorbed energy, so, the wavelength of 
emmision will be longer than the wavelength of absorption, and will give a different colour 
of light (Adan et al., 2017; Lichtman & Conchello, 2005). The difference between excitation 
energy and emmision energy is known as Stokes Shift . Fluorescence studies uses this 
principle to determine good fluorophores, and when fluorescent molecules have a large 
stokes shift, detection of different molecules is easier using confocal microscopy or flow 




Figure 5. Stokes shift diagram. This illustration explains the whole process of fluorescence 
production. (1) the electron is on the ground state, and absorbs reflected light (excitation), 
and transits to its maximum excited state. (2) the excited state lasts for a few nanoseconds, 
and releases some absorbed energy, giving off heat. (3) the electron falls to a stable energy 
state, the relaxed state. (4)  the electron starts moving to the ground state, emitting the re-
maining absorbed energy as fluorescence (emission energy). Adapted from  Rahman et al., 
2006. 
In this study, GFP (excitation_Ex = 488nm, emmision_Em = 510nm) was used as a 
fluorescent marker, and it was introduced to the UPEC CFT073 using two different plasmids 
to make two different bacterial bioreporters, pET-GFP_mut2_KAN®, and pSC101-
GFP_Δscarlet_AMP®. The first one needs IPTG molecule to induce its GFP expression, 
while the second one always expresses its GFP. 
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2 THE AIMS OF THE THESIS 
The main aim of this work was to optimize bacterial growth conditions, so that eventually 
bacteria can be used in cell culture infection assays.  
For that purpose, we tested:  
• Bioreporter’s fluorescence levels (GFP)  
• Internalization rate and intracellular survival (in bladder cells) 
The ideal bacterial growth conditions result in unhampered production of reporter proteins 
(high levels of green fluorescence) and do not affect expression of bacterial surface virulence 




3 EXPERIMENTAL PART  
 
3.1 MATERIALS AND METHODS 
3.1.1 Bacterial strain and preparation of dimethyl sulfoxide (DMSO) stocks 
 CFT073 strain of E. coli (Mobley,’ et al., 1990) was used in all experiments. Bacteria, from 
glycerol stock was streaked on LB agar plate, incubated over night at 37 °C and next day a 
single colony was taken for making a DMSO stock. With a plastic loop the colony was 
transferred into 10 ml of LB media and bacteria was grown over night, 37 °C, 120 rpm shak-
ing conditions. The subsequent day, overnight culture was 100x diluted into fresh LB media 
and placed back into the shaker at 37 °C. When optical density (OD600) of culture reached 
0.8, DMSO was added to the final concentration of 8%, and cells were stored in 120 µl 
aliquots at -80 °C. 
3.1.2 Making electrocompetent cells 
To make the cells electrocompetent, overnight culture of CFT073 wild type (WT), that was 
cultured in LB, 37 °C, 120 rpm shaking conditions, was 100x diluted in 50 ml super optimal 
broth media (SOB) and put to grow in 37°C shaker incubator. Once OD600 reached 0,35 – 
0,4 the cells were immediately put on ice for 20 – 30 minutes, swirling occasionally to allow 
even cooling. Afterwards, the entire 50 ml culture was poured into a cold 50 ml tube, and 
centrifuged at 3000 g for 10 minutes at 4°C. The supernatant was removed and pellet was 
resuspended in 10% glycerol. The process was repeated consecutively three more times. 
Eventually, the cells were resuspended in 400 µl of 10% glycerol, aliquoted, 50 µl each tube 
and used immediately for transformation. The remaining tubes with electrocompetent cells 
were stored at -80°C.  
3.1.3 Bacterial transformation by electroporation  
Bacterial transformation is the process where we take advantage of lateral gene transfer to 
insert foreign genetic information into a bacterial cell. Bacterial transformation by electro-
poration involves the use of an electroporator to intentionally create holes in the bacterial 
cells, so the bacteria can take up the genetic information in its environment. 
All materials used, liquids, as well as bacterial cells were prechilled on ice for approx. 20-
30 minutes before transformation. One aliquot of the electrocompetent cells (50 µl) was 
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mixed with the plasmid (100ng/µl) and then added into the electroporation cuvette (2mm). 
Electroporation was then done by applying 2500 voltage in electroporator, and afterwards 
cells were recovered by incubation in 1ml of warm nutrient rich media (LB). When cells 
were transformed with plasmid carrying kanamycin resistance gene 
(pET_GFP_mut2_KAN®), recovery- incubation time was for 1 hour, but when cells were 
transformed with plasmid carrying ampicillin resistance gene (pSC101_GFPΔscar-
let_AMP®) recovery- incubation time was for half an hour.   
After the period of incubation, the cells were centrifuged for 30 seconds at 15000 rpm, 900 
µl of supernatant was removed, and the pellet was resuspended in remaining 100 µl of LB 
and plated on LB agar plates containing the appropriate antibiotic for selection (25 µg/ml of 
kanamycin or 100µg/ml of ampicillin).  
Successfully transformed bacteria formed colonies on selective agar plates, and one was 
taken for making 8% DMSO stock (described above).  
3.1.4 Optimization of bacterial growth 
Bacterial growth was tested in both liquid and solid nutrient media (with addition of agar up 
to 1.5%).  
In case of the liquid media, we tested the growth in LB at static (in incubator 37 °C) and 
shaking conditions (37 °C, 120 rpm). Bacteria from DMSO stock was 100x diluted into LB 
medium, with addition of selective antibiotic (kanamycin or ampicillin, 25 and 100 µg/ml 
respectively).  
Bacteria transformed with pSC101_GFP_Δscarlet_AMP® plasmid can constitutively ex-
press green fluorescent protein (GFP), while bacteria transformed with 
pET_GFP_mut2_KAN®, need 1mM isopropyl β-D-1-thiogalactopyranoside (IPTG) to be 
added into growth media to induce GFP expression.  
For optimization of bacterial growth on solid nutrient media we had used different types of 
media: lysogeny broth (LB), super optimal broth (SOB), trypticase soy broth (SOY), 
mueller-hinton broth (MHB), and 2x yeast tryptone broth (2x YT). From the DMSO stock, 
100 µl of bacteria was directly taken and used for spreading on the top of agar plates, using 
a glass spreader.  
The next day, bacterial samples were prepared for flow-cytometry analysis (FACS) (de-
scribed below in the text) and for determination of colony forming units (CFUs). Firstly, we 




CFU/ml). For bacteria growing on top of solid media, we used plastic loops to collect and 
inoculate them into 1xPBS, and eventually OD600 was also adjusted to 1. Afterwards, serial 
dilutions were made to adjust bacterial concentration to 106 CFU/ml (optimal for FACS anal-
ysis). Samples were further prepared for flow cytometry analysis and appropriate dilutions 
plated on LB agar plates (with glass beads) for CFU/ml determination. All experiments were 
repeated three times. 
3.1.5 Fluorescence-activated single cell sorting (FACS) 
Flow cytometry is a method that enables detection and quantification of characteristics of 
cell populations or particles using a flow cytometer. A flow cytometer analyzes cell or par-
ticle populations by passing them singularly through lasers using hydrodynamic focusing. 
The particles are examined for visible light scatter and fluorescence parameters. The light 
scatter can be measured in two directions, at 90° (side scatter, SSC) which shows the cell or 
particle granularity, or at forward direction (forward scatter, FSC) which is used to show 
relative size of the cell or particle. Samples analyzed with a flow cytometer usually express 
fluorescent proteins or are stained with fluorophores(McKinnon, 2018; Rahman et al., 2006). 
Sample preparation: After adjusting concentration of bacteria to 106 CFU in 1ml of 1x PBS, 
250µl of cell suspension was transferred into two Eppendorf tubes which were then centri-
fuged at 15000 rpm for 5 minutes. Pellet was dissolved in 1ml of 1xPBS. Eventually, in the 
one tube we added MM dye (Ex=558nm, Em=734nm) to final concentration of 2µg/ml. MM 
stains all the cell membranes red. In the second tube we did not add any dye. After 15 min 
of incubation at room temperature samples were analyzed using a flow cytometer (Attune 
NxT Flow Cytometer).  
3.1.6 Bladder cell infection protocol 
For establishing the model of in vitro-cell culture infection model we used bladder epithelial 
cancer cell line 5637 (ATCC® HTB-9™). Bladder cells were seeded in 12- well plates, in 
2ml of RPMI-1640 (ThermoFisher) media, supplemented with 10% fetal bovine serum 
(FBS), at concentration of 4*104 cells/ml. Plates were then incubated at 37°C in presence of 
5% CO2 for two days, so the confluency of cells on the day of infection was about 80-90% 
(coverage of the well bottom). On another hand, bacteria for infection (CFT073_pSC101-
GFP_Δscarlet amp®) was grown at static conditions in LB broth for 24 hours, then 100x 
diluted into fresh LB medium and grown for additional 24 hours. We also tested in infection 
model bacteria that was grown on the surface of solid media (LB agar plate) for 48 hours.  
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Counting of bladder cells: On the day of infection, one well in 12- well plate was used for 
the determination of number of HTB9 cells. Cells were first detached from well bottom using 
trypsin 0.5 % with EDTA (PAN Biotech) and resuspended in total volume of 2ml in RPMI 
10% FBS. 10 µl of cell suspension was further mixed with 10 µl of trypan blue dye, incu-
bated for 5 minutes at room temperature. Automated cell counter (InvitrogenTM Countess) 
was used to define the number of bladder cells.  
Infection protocol: For infection of bladder cells, we used multiplicity of infection 50 
(MOI50; 50 bacterial cells per one eukaryotic cell). 2 ml of RPMI media with 10% FBS, 
containing bacteria, was added into each well on top of the bladder cells. Plates were then 
centrifuged at 1000 rpm for 5 minutes to provide better attachment of bacteria to the cell 
surface. Followed by 2 hours incubation at 37°C in presence of 5% CO2, allowing bacterial 
internalization. Non-phagocyted bacteria were killed by 2 hours incubation in presence of 
100 µg/ml of gentamicin and washed with 1xPBS. After this step, initial infection rate (Time 
zero CFU/ml) was determined by lysing of bladder cells in 1ml of filtered (0,20 µm)  distilled 
water. Half of the lysate was used for CFU determination and the other half for FACS 
analysis. The rest of infected wells were incubated for additional 24 hours at 37°C, 5% CO2 
incubator. To prevent extracellular contamination infected cells were incubated with 10 
µg/ml of gentamicin. After the 24 hours incubation period, washing and lysing steps were 
















3.2.1 OPTIMIZATION OF BACTERIAL GROWTH FOR CELL INFECTION ASSAY 
As stated earlier, in this study, two bioreporters were used, all transformed in CFT073. The 
inducible bioreporter containing plasmid pET_GFP_mut2_KAN®, and the constitutively 
expressed bioreporter containing plasmid pSC101_GFPΔScarlet_AMP®.  
To observe if it is possible to optimize bacterial growth without affecting the expression of 
the bacterial bioreporter, the bacteria was grown in different media and conditions. This is 
important in order to detect if bacterial growth conditions in general can affect bioreporter 
expression, detection and internalization. Afterwards, the growth and fluorescence levels 
were quantified and then compared. 
3.2.1.1. pET_GFP_kan® IPTG inducible GFP 
The bacteria transformed with plasmid pET_GFP_KAN® (IPTG inducible expression of 
GFP) was tested at first. This bacterial bioreporter is a lights-on-bioreporter (described under 
bioreporter section), and IPTG is its analyte.  
In this part of the study, the bacteria containing the plasmid mentioned above were grown in 
LB agar, LB liquid shaking and LB liquid static conditions.  
Flow cytometry (FACS) – single cell analysis  
FACS analysis allowed us to analyze fluorescence and size properties at single cell level 
within bacterial populations, which were grown in different conditions.  
Based on presence of green fluorescence, due to expression of GFP bioreporter, we could 
gate bacterial populations, like it is shown on the Figure 6A, B, C. Bacteria grown on LB 
agar surface and in LB liquid with shaking (6A, B) can be easily separated and distinguished 
from the noise (<103). In contrast, bacterial population grown in LB liquid static conditions 
(6C), which is commonly used in infection procedures, shows many events with very low 
GFP levels (close to the threshold). On histogram (6D) is presented overlay of these bacterial 
populations, and in case of static LB liquid conditions, there is clearly distinguishable sub-





Figure 6. Flow cytometry analysis of bacterial populations expressing IPTG inducible 
GFP bioreporter. Bacterial populations were gated based on presence of green fluorescence 
(above the threshold of 103). Gated bacterial populations, presented on panels A, B, and C 
were overlapped and presented in a histogram, shown on panel D.  
In order to find out if there are some bacteria that are not gated due to absence of green 
fluorescence (e.g., loss of plasmid) we used cell membrane dye MM 4-64. As explained in 
the materials and methods- flow cytometry section, MM dye stains cell membrane, hence, 




Figure 7. Flow cytometry analysis of bacterial populations using additional membrane 
dye MM4-64. Bacterial populations were gated based on MM 4-64 staining of the cell’s 
membrane above the threshold. On panel D, gated populations shown on panels A, B, and 
C were overlapped and checked using GFP parameters. 
Firstly, bacterial populations from three different pre-growth conditions, were gated based 
on presence of MM 4-64 dye -red fluorescence (Figure 7A, B, C). On their overlay, shown 
on Figure 7 D, bacteria grown in static liquid conditions is forming a huge subpopulation of 
cells that do not express green fluorescence, but have red fluorescence (membrane dye). Last 
but not least, we wanted test if cell viability is affected, by defining CFU/ml and comparing 
it with FACS events/ml.    
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Correlation between CFU/ml vs FACS events/ml 
 
Subsequently, CFU- and FACS events per ml were defined and compared.  
 
Figure 8. Comparison of CFU and FACS data of bacterial populations from three differ-
ent pre-growth conditions. CFU/ml is presented with blue bars. FACS events expressing 
GFP in green bars and events with red fluorescence (MM 4-64 dye) with red bars. 
In Figure 8, CFU count shows that all bacteria are viable, and the FACS events supports this 
data and correlates with it. However, in the case of LB liquid static, there is a slight decrease 
in GFP expressing populations. 
3.2.1.2. pSC101_GFPΔscarlet AMP® 
The next bioreporter that we have tested is a lights-off bioreporter (explained under biore-
porter section), and it constitutively expresses it’s GFP. Here, bacterial growth was exam-
ined on solid media (LB with and without AMP; SOY, SOB, MHB) and liquid LB media 
(static and shaking conditions).  
Flow cytometry (FACS) – single cell analysis 
FACS samples were analyzed in the same way as for previously examined bioreporter. On 
Figure 9 is presented gating of bacterial populations cultured in LB liquid (shaking, static) 
and on LB agar plates. However, gating of populations cultured in other types of media is 
presented in the appendix 1. In LB agar, LB liquid shaking, the bacteria expression of GFP 
is easily separated from the threshold (<103). On the other hand, bacteria grown in LB liquid 
static conditions (9C), show events with very low GFP levels (close to threshold). To see the 






























showing the three GFP expressing population that was gated. On the histogram, in the case 




Figure 9. Flow cytometry analysis of bacterial populations of constitutively expressed 
GFP bioreporter. Bacterial populations were gated based on presence of green fluorescence 
(above the threshold of 103). Gated bacterial populations, presented on panels A, B, and C 
were overlapped and presented in a histogram, shown on panel D. The rest of the tested 
media overlay is included, but gating data is in appendix 1. 
From this result, some bacteria grown in LB liquid static conditions are also below the 
threshold due to loss of GFP expression like in the first experiment. To see the population 
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of bacteria that were not gated due to absence of green fluorescence, we used MM 4-64 to 
stain the cell membranes. 
 
 
Figure 10. MM dyed populations. Bacterial populations were gated based on MM 4-64 
staining of the cell’s membrane above the threshold. On panel D, gated populations shown 
on panels A, B, and C were overlapped and checked using GFP parameters. The rest of the 
tested media gating is in appendix 1, but the overlay is seen in Figure 10D. 
Firstly, bacterial populations from three different pre-growth conditions, were gated based 
on presence of MM 4-64 dye or red fluorescence (Figure 10A, B, C). On Figure 10 D, bac-
teria grown in static liquid conditions is forming a huge subpopulation of cells that do not 
express green fluorescence but have red fluorescence (membrane dye). Finally, we checked 
cell viability, by defining CFU/ml and comparing it with FACS events/ml.    
CFU vs FACS 




Figure 11. CFU vs FACS data comparison of bacterial populations from three different 
pre-growth conditions. As the legend above describes, CFU/ml is shown with blue bars. For 
FACS events, green bars show GFP expressed events, and red bars show population ex-
pressing red fluorescence. 
Overall, high bacterial bioreporters growth and GFP expression are not mutually exclusive 
and is achievable as seen in bacterial bioreporters grown on LB agar. With this bioreporter, 
as noticed in the previously tested bioreporter, LB liquid static grown bacteria tends to lose 
more fluorescence expression compared to other conditions.  
3.2.1.2 Cell culture infection assay  
Apart from testing bioreporter’s fluorescence levels under different growth conditions, my 
supervisor Ivana Kerkez tested internalization rate using CFT073 strain transformed with 

































Figure 12. Effect of bacterial pre-growth conditions on internalization rate in bladder 
epithelial cells. Samples for CFU determination (blue bars) and FACS analysis (red bars) 
were taken just after infection of cells (0h) and after 24 h of incubation with low concentra-
tions of gentamicin (10 µg/ml).  
The internalization rate of the bacteria bioreporter mentioned above was tested. Bacteria 
grown on agar plates had a lower internalization than bacteria grown in LB liquid static 
conditions. Generally, there is a ≥3 log difference between CFU and FACS for both LB 
liquid static and LB agar grown bacteria. That might be because dead bacteria are firmly 
attached to the surface of the bladder cells and that’s why they can be detected by FACS 
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3.3 DISCUSSION 
Bacteria transformed with the two bioreporters (IPTG induced bioreporter, constitutively 
expressed bioreporter) exhibited unhampered growth in all examined growth. However, we 
noticed that some growth conditions might affect fluorescence expression. 
According to the FACS analysis, both IPTG induced bioreporter and constitutively ex-
pressed bioreporter exhibited more loss of GFP fluorescence expression in LB liquid static 
growth compared to the other growth conditions. It was surprising to encounter these results 
because in most previous researches, all infections were always done with bacteria grown in 
LB liquid static conditions e.g., (Blango & Mulvey, 2010; Justice et al., 2004). 
However, maybe we found a solution, our data suggests that for cell infections, bacteria 
grown on LB agar is more suitable, as fluorescence is not lost. 
Furthermore, after infecting bladder cells with the bacteria, we found a compromising result. 
The LB agar cells had slightly lower internalization rate compared to LB liquid static grown 
bacteria. Our infection model showed big FACS – CFU difference suggesting that most were 
dead and attached to the surface of the bladder cells. To use this data in the future, we must 
find a better way to properly lyse the extracellular bacterial cells. 
The entire results imply that even if we had great bacterial bioreporters growth or GFP ex-
pression during the initial optimization, the same cannot be said for its internalization, and 
reporter expression in the bladder cells. A classic example is seen in the lower internalization 
rate of bioreporters grown in LB agar conditions using constitutively expressed GFP biore-
porters. Another example is seen in LB static grown bacteria bioreporter. One possible hy-
pothesis is that some of the liquid static grown bacteria used their ATP to synthesize pili 
instead of expressing GFP, and might have lost the plasmid since it was of no use. Bacteria 
are highly adaptable organisms, and there is no surprise if this is the case. But these must be 
subject to further research for confirmation. 
While there has been little documented study on the optimization of bioreporters for usage 
in cell culture infection models, getting these results means a lot for the further development 
of UTI studies. It means easier observation of the intracellular lifestyle of bacteria without 
having to inoculate for several days and harvest organs for inspection. If these bioreporters 
could be further developed for cell culture infections, it will create a great way to study and 




Whole cell bioreporters are slowly gaining its importance in cell culture infection models. 
They can be used to detect different bacteria internalization rate and make the study of cell 
infections easier.  
In this study, we used two bioreporters, one was an inducible bioreporter (IPTG inducible 
GFP bioreporter) transformed with plasmid pET_GFP_KAN®, and the other was a consti-
tutively expressed bioreporter (constitutively expressed GFP) transformed with plasmid 
pSC101_GFPΔscarlet_AMP®. The bioreporters were selected with their antibiotic markers, 
and bacterial growth conditions were subsequently optimized. 
The optimization experiment included the growing of bacteria overnight in different media 
and conditions – on lysogeny broth (LB), mueller-hinton broth, super optimal broth, trypti-
case soy broth, and in LB liquid static, LB liquid shaking conditions (200 rpm) all in 37°C. 
Afterwards, the bioreporter samples were analysed using CFU and FACS. 
Both bioreporters carrying E. coli strains grow well in all tested condition. But one thing that 
was not expected was the lower fluorescence expression in LB liquid static grown biore-
porter compared to the other growing style. This was not expected because this is the style 
normally used for growing bacteria in various research infection assays. 
When the bladder cells were infected with these bioreporters grown on the LB agar had nice 
internalization and GFP expression in the bladder cells. Bacteria from LB static growth con-
dition had slightly better internalization, but lower GFP fluorescence. One theory is that 
some of the liquid static grown bacteria used their ATP to synthesize pili in the liquid media 
instead of expressing GFP and might have lost the plasmid since it was of no use. 
In conclusion, this study shows that LB agar grown bacterial bioreporter is the best for in-
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I. GFP and MM 4-64 gating of SOB, SOY, MHB, LB agar (with and without 
AMP) 
 
Figure 13. FACS analysis of bacterial population constitutively expressing GFP. 
Bacterial populations were gated based on the expression of GFP. LB agar was added here 







Figure 14. FACS analysis of bacterial population constitutively with MM stained 
membranes. Bacterial populations were gated based on MM 4-64. LB agar was again added 
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